Consequently, pharmacological or siRNA-mediated inhibition of Jak2 or Lyn reduces tyrosine phosphorylation of Gab2 in CML cells. This evidence concerns the gene JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive.